Novartis wins FDA approval for two blood pressure drugs
Novartis obtained FDA clearance for Diovan HCT and Exforge, two single-pill treatments for high blood pressure. The approval allows the use of the combination drugs as an initial treatment for hypertension patients who may need multiple regimens, the company said.
Bloomberg | 08/04
This story published in AHIP Solutions SmartBrief on 08/04/2008
More from SmartBrief:
Researchers trace memory problems to high blood pressure
Wednesday, August 26, 2009
Smoking, hypertension, diabetes raise dementia risk
Friday, August 21, 2009
Study: Dieting might be easier with alternate-day fasting
Monday, November 16, 2009
Get stories like these delivered daily for FREE:
|
AHIP Solutions SmartBrief
Designed specifically for health care executives like you, AHIP Solutions SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more |
|